CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
|
| Income Statement [Abstract] | ||
| Revenues (Note 9) | $ 244,000 | |
| Cost of revenues | 40,000 | |
| Gross profit | 204,000 | |
| Profit from sale of operations, net | 754,000 | |
| Operating expenses: | ||
| Research and development | 48,000 | |
| Selling and marketing | 43,000 | |
| General and administrative | $ 164,000 | 463,000 |
| Total operating expenses | 164,000 | 554,000 |
| Operating Profit (Loss) | (164,000) | 404,000 |
| Financial expenses | (10,000) | $ (30,000) |
| Financial income related to convertible notes and warrants | 35,000 | |
| Total financial income (expenses), net (Note 8) | $ 25,000 | $ (30,000) |
| Other income (expense) | (12,000) | |
| Net profit (loss) | $ (139,000) | $ 362,000 |
| Net profit (loss) per share: | ||
| Basic and diluted | $ 0.01 | |
| Weighted average number of common stock used in computing basic and diluted net loss per share | 43,173,592 | 43,173,592 |